diabetes
Pharmacist-Managed Diabetes Program Slashes HbA1c Levels
A pharmacist-managed diabetes care program reduced hemoglobin A1c levels from approximately 9.4% at baseline to ...
AUGUST 17, 2025
‘GLP-1s for Everything!’: Balancing Access With Sustainability
Glucagon-like peptide-1 receptor agonists are moving far beyond their established uses for managing type 2 diabetes ...
AUGUST 16, 2025
Steroid Use During COVID-19 Creates Perfect Storm for Fungal Infections
Environmental factors; high rates of diabetes; and a widespread use of steroids during the COVID-19 pandemic ...
JUNE 23, 2025
Pharmacist-Managed Diabetes Program Significantly Cuts A1c Levels
A pharmacist-managed diabetes care program slashed hemoglobin A1c levels by nearly two full points, according to ...
JUNE 12, 2025
Top TOC Challenges: Anticoagulants, Diabetes Rx and Opioids
Whether from inpatient to outpatient, outpatient to inpatient, or between higher and lower-acuity settings within ...
MARCH 18, 2025
FDA Issues Alert About Smartphone-Compatible Diabetes Devices
The FDA issued a communication regarding difficulties with critical safety alerts intended to be delivered via ...
FEBRUARY 6, 2025
GLP-1s Contribute to Lower Risk for VTE in Patients With Diabetes
People with diabetes treated with GLP-1 agonists were 20% less likely to experience VTEs than similar patients who ...
DECEMBER 9, 2024
Taking the RA Threat to Heart During Pregnancy
Obesity, gestational diabetes mellitus and acute cardiovascular complications are more common among pregnant women ...
NOVEMBER 20, 2024
Pharm Capsules
The GLP-1 receptor agonist semaglutide helps prevent the progression of chronic kidney disease in patients with ...
OCTOBER 4, 2024
New-Onset Diabetes Is an Early Clue to Pancreatic Cancer
New-onset diabetes in adults older than 50 years of age could be a manifestation of pancreatic cancer, according to ...
SEPTEMBER 23, 2024
Report: GLP-1 Adherence Rates Lower Than Expected
Glucagon-like peptide-1 agonists have exploded in use and popularity to treat obesity in nondiabetic patients since ...
JULY 25, 2024
Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes
This Special Report reviews data on the use of dalbavancin for the treatment of ABSSSIs to support safety and ...
JULY 9, 2024
